Abstract:In order to simultaneously achieve photothermal properties, photodynamic effects and second near-infrared (NIR-II 1000-1700 nm) fluorescence emission of conjugated polymers, herein a novel ternary conjugated polymer (BDP) was designed and synthesized by copolymerization of an electron-withdrawing monomer diketopyrrolopyrrole and two electron-donating monomers (benzodithiophene derivatives and 1,10-phenanthroline). Then water-soluble nanoparticles (BDP NPs) were further prepared by self-assembling with amphiphilic Pluronic F127 through nanoprecipitation method. The nanoparticles with a diameter of around 90 nm exhibited excellent stability in aqueous solution. The absorption and emission peaks of BDP NPs were determined to be 735 nm and 1039 nm, respectively. The mass extinction coefficient of the nanoparticles was as high as 4.67 mL/(mg center dot cm) the fluorescence quantum yield of BDP NPs was measured to be 0.62% by using IR-26 as a reference, and the photothermal conversion efficiency was 18.2%. Under 730 nm laser irradiation, the temperature of BDP NPs (150 mu g/mL) can reach 64 degrees C, which was high enough for photothermal therapy. Besides, the BDP NPs also produce reactive oxygen species with the same laser, which can be used for photodynamic therapy. Cell experiments confirmed that there was no obvious dark toxicity to both NIH3T3 cells and HeLa cells. While under NIR laser irradiation, strong phototoxicity toward cancer cells was observed, indicating the high therapeutic efficacy with the combination therapy. After intravenous injection of BDP NPs, the blood vessels in living mice can be observed which confirmed the high resolution of NIR-II imaging. Importantly, the BDP NPs can accumulate at the tumor sites at 12 h post-injection, indicating the possibility of NIR-II imaging guided combination therapy in vivo. Overall the obtained BDP NPs with high biocompatibility strong absorption in the first near-infrared (NIR-I, 650- 900 nm) range, intense emission in NIR-II region, and the ability to produce reactive oxygen species and hyperthermia were, excellent candidate for tumor diagnosis and phototherapy. In addition, this work also provides a promising method for the rational design of conjugated polymer-based high performance phototheranostic nanoplatforms. [GRAPHICS] .

Cell-Penetrating Peptide-Conjugated BF2 -Oxasmaragdyrins as NIRF Imaging and Photothermal Agents

A Novel TMTP1-modified Theranostic Nanoplatform for Targeted in Vivo NIR-II Fluorescence Imaging-guided Chemotherapy of Cervical Cancer

Pegylated Conjugated Polyelectrolytes Containing 2,1,3-Benzoxadiazole Units for Targeted Cell Imaging

BF2-Oxasmaragdyrin Nanoparticles: A Non-toxic, Photostable, Enhanced Non-radiative Decay-Assisted Efficient Photothermal Cancer Theragnostic Agent

A Lipophilic IR-780 Dye-Encapsulated Zwitterionic Polymer-Lipid Micellar Nanoparticle for Enhanced Photothermal Therapy and NIR-Based Fluorescence Imaging in a Cervical Tumor Mouse Model

Facile development of biodegradable polymer-based nanotheranostics: Hydrophobic photosensitizers delivery, fluorescence imaging and photodynamic therapy

Molecular Cancer Imaging in the Second Near‐Infrared Window Using a Renal‐Excreted NIR‐II Fluorophore‐Peptide Probe

Cell-Penetrating Peptides Transport Noncovalently Linked Thermally Activated Delayed Fluorescence Nanoparticles For Time-Resolved Luminescence Imaging

Antiaggregation of NIR-II Probe Regulated by Amphiphilic Polypeptide with High Contrast Brightness for Phototheranostics and Vascular Microscopic Imaging under 1064 nm Irradiation

Fused-Ring Small-Molecule-Based Bathochromic Nano-agents for Tumor NIR-II Fluorescence Imaging-Guided Photothermal/Photodynamic Therapy

Bright Far-Red/near-infrared Fluorescent Conjugated Polymer Nanoparticles for Targeted Imaging of HER2-positive Cancer Cells

A computational and experimental investigation of donor-acceptor BODIPY based near-infrared fluorophore for in vivo imaging

ATernary Conjugated Polymer for NIR-II Fluorescence Imaging and Photothermal/Photodynamic Combination Therapy

On-demand drug release nanoplatform based on fluorinated aza-BODIPY for imaging-guided chemo-phototherapy

Nanoparticles destabilizing the cell membranes triggered by NIR light for cancer imaging and photo-immunotherapy

Black Phosphorus Quantum Dots Gated, Carbon-Coated Fe3 O4 Nanocapsules (BPQDs@ss-Fe3 O4 @C) with Low Premature Release Could Enable Imaging-Guided Cancer Combination Therapy

Butyrylcholinesterase Responsive Supramolecular Prodrug with Targeted Near‐infrared Cellular Imaging Property

Acid-Responsive Polymeric Doxorubicin Prodrug Nanoparticles Encapsulating a Near-Infrared Dye for Combined Photothermal-Chemotherapy

Targeted Antimicrobial Peptide Delivery in Vivo to Tumor with Near Infrared Photoactivated Mesoporous Silica Nanoparticles

Dual Ph-Responsive Polypeptide Nanoprobes for Lysosomes Enhanced Bioimaging and Tumor Photothermal Therapy under 1064 Nm Irradiation

Bioinspired Fluorescent Dipeptide Nanoparticles for Targeted Cancer Cell Imaging and Real-Time Monitoring of Drug Release